Mechanisms of tumor-related brain edema.

Cerebral edema contributes strongly to symptoms associated with brain tumors. Although the introduction of corticosteroids has greatly simplified treatment of patients with newly diagnosed tumors, these drugs are associated with marked side effects during the long-term treatment that is often necessary in the recurrences. Therefore, a better understanding of mechanisms related to the evolution and clearance of tumor-related edema with the aid of modern imaging and molecular methodology is clearly necessary. Recently, researchers have focused on molecular mechanisms of edema development and have demonstrated alternative routes-such as the inhibition of vascular endothelial growth factor receptor inhibitors-to be explored for treating edema. In this review the author focuses on established and current concepts regarding the pathophysiology of cerebral edema and its treatment.

[1]  Christopher Nimsky,et al.  Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. , 2006, Radiology.

[2]  Thomas H. Mareci,et al.  Computational Model of Interstitial Transport in the Spinal Cord using Diffusion Tensor Imaging , 2006, Annals of Biomedical Engineering.

[3]  W. Hall,et al.  Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme. , 2006, Neurosurgical focus.

[4]  M. Bastin,et al.  Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. , 2006, AJNR. American journal of neuroradiology.

[5]  C. Bokemeyer,et al.  Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416 , 2006, Leukemia & lymphoma.

[6]  E. Oldfield,et al.  A reassessment of vascular endothelial growth factor in central nervous system pathology. , 2005, Journal of neurosurgery.

[7]  J. Bussink,et al.  Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line. , 2005, International journal of radiation oncology, biology, physics.

[8]  Yukihiko Fujii,et al.  Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema. , 2005, Journal of neurosurgery.

[9]  J. Abbruzzese,et al.  Celecoxib Inhibits Vascular Endothelial Growth Factor Expression in and Reduces Angiogenesis and Metastasis of Human Pancreatic Cancer via Suppression of Sp1 Transcription Factor Activity , 2004, Cancer Research.

[10]  E. Anaissie,et al.  Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma , 2004, Clinical Cancer Research.

[11]  N. Nathoo,et al.  The eicosanoid cascade: possible role in gliomas and meningiomas , 2003, Journal of clinical pathology.

[12]  M. Lauritzen,et al.  Nitric oxide synthase expression and enzymatic activity in human brain tumors. , 2003, Clinical neuropathology.

[13]  F. Cavalli,et al.  A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. , 2003, Blood.

[14]  Harumi Itoh,et al.  Peritumoral brain edema in intracranial meningiomas evaluated by dynamic perfusion-weighted MR imaging: a preliminary study , 2003, European Radiology.

[15]  D. Resnick,et al.  Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  Mark E Bastin,et al.  Measurements of water diffusion and T1 values in peritumoural oedematous brain , 2002, Neuroreport.

[17]  V. Glauche,et al.  Correlation of Apparent Diffusion Coefficient and Computed Tomography Density in Acute Ischemic Stroke , 2002, Stroke.

[18]  D. Davies,et al.  Blood–brain barrier breakdown in septic encephalopathy and brain tumours * , 2002, Journal of anatomy.

[19]  M. Papadopoulos,et al.  Aquaporin-4 expression is increased in oedematous human brain tumours , 2002, Journal of neurology, neurosurgery, and psychiatry.

[20]  M. Papadopoulos,et al.  Occludin expression in microvessels of neoplastic and non‐neoplastic human brain , 2001, Neuropathology and applied neurobiology.

[21]  T. Kuno,et al.  Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged the survival. , 2001, The Kobe journal of medical sciences.

[22]  K. Kono,et al.  The role of diffusion-weighted imaging in patients with brain tumors. , 2001, AJNR. American journal of neuroradiology.

[23]  J. Dichgans,et al.  Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15 , 2001, Neurology.

[24]  M. C. Papadopoulos, S. Saadoun, D. C. Davies, B. A. B Emerging molecular mechanisms of brain tumour oedema , 2001 .

[25]  K. Plate,et al.  VEGF in Brain Tumors , 2000, Journal of Neuro-Oncology.

[26]  S. Liebner,et al.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.

[27]  U. Bode,et al.  Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors. , 2000, Klinische Padiatrie.

[28]  S. Orrenius,et al.  Dexamethasone pre-treatment interferes with apoptotic death in glioma cells , 2000, Neuroscience.

[29]  M. Delgado,et al.  Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. , 1999, Journal of neurosurgery.

[30]  W. Mayhan VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. , 1999, American journal of physiology. Cell physiology.

[31]  K. Plate,et al.  Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors. , 1999, Neurosurgery.

[32]  Machein,et al.  Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells , 1999, Neuropathology and applied neurobiology.

[33]  B. Rosen,et al.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.

[34]  C. Andersen The effect of glucocorticoids in the normal cerebral hemisphere of brain tumour patients , 1998, Acta neurologica Scandinavica.

[35]  W. Cavenee,et al.  Expression of vascular endothelial growth factor in human brain tumors , 1998, Acta Neuropathologica.

[36]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[37]  Kazushi Fujimoto,et al.  Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.

[38]  Y. Hirashima,et al.  Platelet-activating factor and edema surrounding meningiomas. , 1998, Journal of Neurosurgery.

[39]  V. Speirs,et al.  Constitutive co‐expression of estrogen and progesterone receptor mRNA in human meningiomas by RT‐PCR and response of in vitro cell cultures to steroid hormones , 1997, International journal of cancer.

[40]  S. Leung,et al.  Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma. , 1997, The American journal of surgical pathology.

[41]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[42]  C. Palmer,et al.  Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. , 1997, Neurosurgery.

[43]  A. Guha,et al.  Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. , 1997, Neurosurgery.

[44]  G. Palade,et al.  Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.

[45]  A. von Deimling,et al.  Expression and distribution of vascular endothelial growth factor protein in human brain tumors , 1997, Acta Neuropathologica.

[46]  P. Agre,et al.  Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain , 1997, The Journal of Neuroscience.

[47]  S. Kalkanis,et al.  Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. , 1996, Journal of neurosurgery.

[48]  E. Papavassiliou,et al.  Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. , 1996, The Journal of clinical investigation.

[49]  D. Mukhopadhyay,et al.  Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. , 1995, Cancer research.

[50]  T. Shono,et al.  Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. , 1995, Cancer research.

[51]  G. Criscuolo,et al.  Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. , 1994, Journal of neurosurgery.

[52]  T. Kawanami,et al.  Electron microscopy of the blood‐brain barrier in disease , 1994, Microscopy research and technique.

[53]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[54]  Criscuolo Gr The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. , 1993 .

[55]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[56]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[57]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[58]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[59]  D. Connolly Vascular permeability factor: A unique regulator of blood vessel function , 1991, Journal of cellular biochemistry.

[60]  G. Butti,et al.  A study on the biological behavior of human brain tumors Part I. Arachidonic acid metabolism and DNA content , 1991, Journal of Neuro-Oncology.

[61]  P. McL. Black,et al.  Human meningiomas co‐express platelet‐derived growth factor (pdgf) and pdgf‐receptor genes and their protein products , 1990, International journal of cancer.

[62]  J. Posner,et al.  Temporal effects of dexamethasone on blood-to-brain and blood-to-tumor transport of 14C-alpha-aminoisobutyric acid in rat C6 glioma , 1990, Journal of Neuro-Oncology.

[63]  H. Tenjin,et al.  Metabolic and hemodynamic aspects of peritumoral low-density areas in human brain tumor. , 1990, Neurosurgery.

[64]  E. Oldfield,et al.  Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. , 1989, Journal of neurosurgery.

[65]  K. Go,et al.  Peritumoral brain edema associated with meningiomas. , 1988, Neurosurgery.

[66]  C C Chang,et al.  Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. , 1988, Journal of neurosurgery.

[67]  J. Bruce,et al.  Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. , 1987, Journal of neurosurgery.

[68]  P. Stewart,et al.  Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. , 1987, Journal of neurosurgery.

[69]  K. Black,et al.  Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans , 1986, Annals of neurology.

[70]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[71]  D. Long,et al.  Capillary ultrastructure in human metastatic brain tumors. , 1979, Journal of neurosurgery.

[72]  H. Reulen,et al.  Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema. , 1978, Journal of neurosurgery.

[73]  D. Long Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. , 1970, Journal of neurosurgery.

[74]  P. Bucy,et al.  The treatment of glioblastoma multiforme of the brain. , 1967, Journal of neurosurgery.

[75]  N. Ruderman,et al.  Use of glucocorticoids in the palliative treatment of metastatic brain tumors , 1965, Cancer.

[76]  Tracy T Batchelor,et al.  AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.

[77]  W. Hall,et al.  Convection-enhanced delivery: targeted toxin treatment of malignant glioma. , 2006, Neurosurgical focus.

[78]  T. Schallert,et al.  Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models. , 2005, Acta neurochirurgica. Supplement.

[79]  K. Voigt,et al.  Peritumoural brain oedema in intracranial meningiomas: Influence of tumour size, location and histology , 2005, Acta Neurochirurgica.

[80]  H. Reulen,et al.  Formation and propagation of brain oedema fluid around human brain metastases. A CT study , 2005, Acta Neurochirurgica.

[81]  S. Shibata Ultrastructure of capillary walls in human brain tumors , 2004, Acta Neuropathologica.

[82]  R. Tanaka,et al.  Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.

[83]  P. Stewart,et al.  A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model , 2004, Acta Neuropathologica.

[84]  M. van Lookeren Campagne,et al.  Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. , 2003, Stroke.

[85]  K. Carson,et al.  A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas. , 2002, Neuro-oncology.

[86]  M. Papadopoulos,et al.  Emerging molecular mechanisms of brain tumour oedema. , 2001, British journal of neurosurgery.

[87]  R. Bullock,et al.  Distinguishing between cellular and vasogenic edema in head injured patients with focal lesions using magnetic resonance imaging. , 2000, Acta neurochirurgica. Supplement.

[88]  S. Liebner,et al.  Liebner, S. et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 100, 323-331 , 2000 .

[89]  T. Hander,et al.  A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[90]  R. Blasberg,et al.  Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. , 1998, In vivo.

[91]  E. Uhl,et al.  Quantitative analysis of brain edema resolution into the cerebral ventricles and subarachnoid space. , 1997, Acta neurochirurgica. Supplement.

[92]  H. Reulen,et al.  Formation and resolution of human peritumoral brain edema. , 1994, Acta neurochirurgica. Supplementum.

[93]  M. Yamamoto,et al.  Peritumoral brain edema and cortical damage by meningioma. , 1994, Acta neurochirurgica. Supplementum.

[94]  G. Criscuolo,et al.  The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. , 1993, The Yale journal of biology and medicine.

[95]  W. Reinhold,et al.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. , 1993, The Journal of clinical investigation.

[96]  H. Reulen,et al.  A computed tomography study on formation, propagation, and resolution of edema fluid in metastatic brain tumors. , 1990, Advances in neurology.

[97]  R. Aaslid,et al.  Fluid flow rates in human peritumoural oedema. , 1990, Acta neurochirurgica. Supplementum.

[98]  H. Reulen,et al.  Peritumoral brain edema. A keynote address. , 1990, Advances in neurology.

[99]  H. Reulen,et al.  Clearance of edema fluid into cerebrospinal fluid , 1983 .

[100]  A. Marmarou,et al.  Biomechanics of brain edema and effects on local cerebral blood flow. , 1980, Advances in neurology.

[101]  H. Reulen,et al.  Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. , 1977, Journal of neurosurgery.

[102]  I. Klatzo,et al.  Presidental address. Neuropathological aspects of brain edema. , 1967, Journal of neuropathology and experimental neurology.